<DOC>
	<DOCNO>NCT02594904</DOCNO>
	<brief_summary>Neonatal Glucose-6-phosphate Dehydrogenase ( G6PD ) Deficiency one significant reason neonatal hyperbilirubinemia even irreversible bilirubin encephalopathy.The neonate may attack due acute infection , eat bean exposure oxidative drug , etc . The main clinical manifestation hemolytic anemia , result hyperbilirubinemia . When bilirubin pretty high body , bilirubin may spread brain , thus cause nervous system damage , severely affect prognosis neonate . Therefore , monitor early intervention jaundice important significance prevent aggravation jaundice certain sequela . Phototherapy exchange transfusion mainly suitable method severe hyperbilirubinemia , however , patient need hospitalize . Yinzhihuang Oral Liquid kind traditional Chinese medicine jaundice . Many large sample multicenter clinical study show positive efficacy Yinzhihuang Oral Liquid treatment neonatal hyperbilirubinemia exactly confirm . The purpose study try detect treatment effect Yinzhihuang Oral Liquid indirect bilirubin neonate G-6-PD enzyme deficiency neonatal hyperbilirubinemia . Try provide scientific theory Yinzhihuang Oral Liquid treat neonates G-6-PD enzyme deficiency neonatal hyperbilirubinemia .</brief_summary>
	<brief_title>Efficacy Yinzhihuang Oral Liquid Indirect Bilirubin Neonates With Glucose-6-phosphate Dehydrogenase Deficiency</brief_title>
	<detailed_description>The primary objective detect treatment effect Yinzhihuang Oral Liquid indirect bilirubin neonate G-6-PD enzyme deficiency neonatal hyperbilirubinemia . Try provide scientific theory Yinzhihuang Oral Liquid treat neonates G-6-PD enzyme deficiency neonatal hyperbilirubinemia . Study subject include neonate hyperbilirubinemia five hospital , willing take Yinzhihuang oral liquid . Five hospital South Hospital Southern Medical University ( primary institute ) , The Third Affiliated Hospital Guangzhou medical university , Shenzhen maternal child health hospital , First Affiliated Hospital Guangxi Medical University , The maternal child health hospital Guangxi Zhuang Autonomous Region Inclusion criteria： 1 . Full-term newborns jaundice 3-7 day birth , total bilirubin serum transcutaneous bilirubin 100umol/L 257umol/L , start take Yinzhihuang oral liquid , dose : 3ml per time , 3 time per day , period , measure bilirubin skin one time every 24 hour ; 2 . Gestational age≥37 week , birth weight≥2.5Kg , Apgar scores≥8 ; 3. lineal consanguinity native resident Guangdong Guangxi ; 4 . The enzyme activity G-6-PD detect collect neonate subject ; 5 . Informed consent neonates subject need . Exclusion Criteria： ( 1 ) Neonates inherit metabolic disease ; ( 2 ) Neonates congenital malformation liver gallbladder ; ( 3 ) Neonates asphyxia , hypoxia , acidosis , sepsis , high fever , low temperature , low protein , low blood sugar , etc . may lead bilirubin encephalopathy ; ( 4 ) History oxidation drug exposure ( e.g . honeysuckle bath ) Study procedures： Outpatient inpatient neonate ( mainly cesarean section newborn ) , jaundice 3-7 day birth , total bilirubin serum measure bilirubin skin 100umol/L 257umol/L , select . On first day jaundice , G-6-PD enzyme activity detect check arterial blood , start take Yinzhihuang oral liquid , dose : 3ml time , 3 time every day , period , measure bilirubin skin one time every 24 hour . When transcutaneous bilirubin 100umol/L , stop take medication . When bilirubin increase match phototherapy indication , neonate transfer neonatal department , continue Yinzhihuang oral liquid treatment bilirubin decrease normal level . transfer ICU still need continue use jaundice decrease normal level . The neonate 's family sign inform consent enter study . G-6-PD &lt; 10.37U /g.H b diagnose lack G-6-PD activity . Subgroup : accord severity lack activity enzyme , divide 3 group : mild deficiency : 6.93-10.37U/g.H b ; moderate deficiency : 3.47-6.92U/g . Hb ; severe deficiency : 0-3.46U/g.H b . Note : criterion modify accord test method five hospital , uniform final standard . The normal value G-6-PD enzyme activity 2.5-5.8KU/L hospital , &lt; 2.5KU/L diagnosed lack G-6-PD enzyme activity . However , certain standard definition mild deficiency , moderate deficiency severe deficiency hospital . It report activity le 10 % normal severe deficiency , le 10 % -60 % normal moderate deficiency , le 60 % normal mild deficiency .</detailed_description>
	<mesh_term>Hyperbilirubinemia</mesh_term>
	<mesh_term>Hyperbilirubinemia , Neonatal</mesh_term>
	<mesh_term>Glucosephosphate Dehydrogenase Deficiency</mesh_term>
	<mesh_term>Bilirubin</mesh_term>
	<criteria>1 . Fullterm newborns jaundice 37 day birth , total bilirubin serum transcutaneous bilirubin 100umol/L 257umol/L , start take Yinzhihuang oral liquid , dose : 3ml per time , 3 time per day , period , measure bilirubin skin one time every 24 hour ; 2 . Gestational age≥37 week , birth weight≥2.5Kg , Apgar scores≥8 ; 3. lineal consanguinity native resident Guangdong Guangxi ; 4 . The enzyme activity G6PD detect collect neonate subject ; 5 . Informed consent neonates subject need . Note : Icterus tester Minolta 105 type . Measurements bilirubin three location , inluding forehead , chest abdomen . The value bilirubin use average value three location , unit umol / L. 1 . Neonates inherit metabolic disease ; 2 . Neonates congenital malformation liver gallbladder ; 3 . Neonates asphyxia , hypoxia , acidosis , sepsis , high fever , low temperature , low protein , low blood sugar , etc . may lead bilirubin encephalopathy ; 4 . History oxidation drug exposure ( e.g . honeysuckle bath )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>7 Days</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>G6PD Deficiency</keyword>
	<keyword>Neonatal Hyperbilirubinemia</keyword>
	<keyword>Yinzhihuang Oral Liquid</keyword>
	<keyword>Indirect Bilirubin</keyword>
</DOC>